• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录因子PATZ1在肿瘤发生和代谢调节中的作用。

The role of the transcription factor PATZ1 in tumorigenesis and metabolic regulation.

作者信息

Zheng Yin, Chen Jiabo, Su Cheng

机构信息

The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.

Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, 530002, China.

出版信息

J Cancer Res Clin Oncol. 2025 Sep 11;151(9):254. doi: 10.1007/s00432-025-06305-8.

DOI:10.1007/s00432-025-06305-8
PMID:40932507
Abstract

PATZ1 (POZ/BTB and AT hook containing zinc finger 1) is an important member of the POZ/BTB (Poxvirus and Zinc finger / Broad-complex, Tramtrack, and Bric-à-brac) family and has been confirmed to be involved in the development and progression of various tumors. Moreover, differential expression of PATZ1 is associated with the prognosis of multiple cancers and systemic metabolic patterns. It participates in the regulation of oncogenes and a range of biological processes, including glucose and lipid metabolism. This review aims to summarize the current understanding of the relationship between the transcription factor PATZ1, tumorigenesis, and metabolism, with the goal of providing a theoretical basis for the development of PATZ1-targeted therapies.

摘要

PATZ1(含POZ/BTB和AT钩结构域的锌指蛋白1)是POZ/BTB(痘病毒和锌指蛋白/广泛复合体、Tramtrack和Bric-à-brac)家族的重要成员,已被证实参与多种肿瘤的发生发展。此外,PATZ1的差异表达与多种癌症的预后及全身代谢模式相关。它参与癌基因的调控以及一系列生物学过程,包括葡萄糖和脂质代谢。本综述旨在总结目前对转录因子PATZ1、肿瘤发生与代谢之间关系的认识,以期为开发以PATZ1为靶点的治疗方法提供理论依据。

相似文献

1
The role of the transcription factor PATZ1 in tumorigenesis and metabolic regulation.转录因子PATZ1在肿瘤发生和代谢调节中的作用。
J Cancer Res Clin Oncol. 2025 Sep 11;151(9):254. doi: 10.1007/s00432-025-06305-8.
2
Glioneuronal tumors PATZ1-fused: clinico-molecular and DNA methylation signatures for a variety of morphological and radiological profiles.伴有PATZ1融合的神经胶质神经元肿瘤:多种形态学和放射学特征的临床分子及DNA甲基化特征
Acta Neuropathol Commun. 2025 May 24;13(1):114. doi: 10.1186/s40478-025-02037-5.
3
Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation.由miR-185-5p、miR-652-5p和miR-1246激活的成纤维细胞通过下调PATZ1塑造三阴性乳腺癌的肿瘤微环境。
Cell Mol Life Sci. 2025 Jul 25;82(1):287. doi: 10.1007/s00018-025-05781-y.
4
An overview of the co-transcription factor NACC1: Beyond its pro-tumor effects.NACC1 共转录因子概述:超越其促肿瘤作用。
Life Sci. 2024 Jan 1;336:122314. doi: 10.1016/j.lfs.2023.122314. Epub 2023 Nov 27.
5
The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement.POZ/BTB 和含有 AT 钩结构域的锌指蛋白 1(PATZ1)转录调节因子:生理功能和疾病相关性。
Int J Mol Sci. 2017 Nov 24;18(12):2524. doi: 10.3390/ijms18122524.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Neuroepithelial tumors of the central nervous system with fusion: a case report and literature review.伴有融合的中枢神经系统神经上皮肿瘤:一例报告及文献复习
Front Oncol. 2025 Jun 12;15:1604479. doi: 10.3389/fonc.2025.1604479. eCollection 2025.
8
PRDM2-The Key Research Targets for the Development of Diseases in Various Systems.PRDM2——各系统疾病发展的关键研究靶点
Biomolecules. 2025 Aug 15;15(8):1170. doi: 10.3390/biom15081170.
9
YAP/TAZ: An epitome of tumorigenesis.YAP/TAZ:肿瘤发生的一个缩影。
Cancer Lett. 2025 Aug 10;625:217806. doi: 10.1016/j.canlet.2025.217806. Epub 2025 May 15.
10
POZ/BTB and AT-Hook-Containing Zinc Finger Protein 1 (PATZ1) Suppresses Progression of Ovarian Cancer and Serves as an Independent Prognosis Factor.POZ/BTB 和 AT 钩状结构域包含锌指蛋白 1(PATZ1)抑制卵巢癌的进展并作为独立预后因素。
Med Sci Monit. 2018 Jun 21;24:4262-4270. doi: 10.12659/MSM.908766.

本文引用的文献

1
Glioneuronal tumors PATZ1-fused: clinico-molecular and DNA methylation signatures for a variety of morphological and radiological profiles.伴有PATZ1融合的神经胶质神经元肿瘤:多种形态学和放射学特征的临床分子及DNA甲基化特征
Acta Neuropathol Commun. 2025 May 24;13(1):114. doi: 10.1186/s40478-025-02037-5.
2
Metabolic reprogramming, sensing, and cancer therapy.代谢重编程、感知与癌症治疗。
Cell Rep. 2024 Dec 24;43(12):115064. doi: 10.1016/j.celrep.2024.115064. Epub 2024 Dec 12.
3
SMURF1 leads to the β-catenin signaling-mediated progression of esophageal squamous carcinoma by losing PATZ1-induced CCNG2 transcription.
Biochem Pharmacol. 2025 Feb;232:116688. doi: 10.1016/j.bcp.2024.116688. Epub 2024 Nov 29.
4
Transcription factor PATZ1 promotes adipogenesis by controlling promoter regulatory loci of adipogenic factors.转录因子PATZ1通过控制脂肪生成因子的启动子调控位点来促进脂肪生成。
Nat Commun. 2024 Oct 2;15(1):8533. doi: 10.1038/s41467-024-52917-y.
5
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.肿瘤起始与早期癌变:分子机制与干预靶点。
Signal Transduct Target Ther. 2024 Jun 19;9(1):149. doi: 10.1038/s41392-024-01848-7.
6
Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery.空间转录组学:疾病理解和药物发现的有力工具。
Theranostics. 2024 May 11;14(7):2946-2968. doi: 10.7150/thno.95908. eCollection 2024.
7
Tumor biomarkers for diagnosis, prognosis and targeted therapy.肿瘤标志物用于诊断、预后和靶向治疗。
Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2.
8
A case of pelvic fusion sarcoma treated with carbon ion radiotherapy.1例盆腔融合肉瘤接受碳离子放射治疗的病例。
Radiol Case Rep. 2024 Apr 16;19(7):2674-2678. doi: 10.1016/j.radcr.2024.03.070. eCollection 2024 Jul.
9
Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology Society.肉瘤研究进展:2023年结缔组织肿瘤学会年会亮点
Mol Ther Oncol. 2024 Mar 2;32(1):200779. doi: 10.1016/j.omton.2024.200779. eCollection 2024 Mar 21.
10
Knockdown of ribosome RNA processing protein 15 suppresses migration of hepatocellular carcinoma through inhibiting PATZ1-associated LAMC2/FAK pathway.敲低核糖体 RNA 加工蛋白 15 通过抑制 PATZ1 相关的 LAMC2/FAK 通路抑制肝癌细胞迁移。
BMC Cancer. 2024 Mar 12;24(1):334. doi: 10.1186/s12885-024-12065-4.